person · Reporting owner
Larsen-Becker Brenda Jane
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Sight Sciences, Inc.SGHT · Entity 5537 | Director | June 05, 2025 | June 10, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Sight Sciences, Inc.
Report date June 05, 2025 · Filed June 10, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,040 |
Reported balance
After 2025-06-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-06-05 · Grant · Acquired 30,952 · Balance 79,040 F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2: Includes (i) 48,088 shares of Common Stock, and (ii) 30,952 RSUs which are subject to vesting as reported herein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
F2: Includes (i) 48,088 shares of Common Stock, and (ii) 30,952 RSUs which are subject to vesting as reported herein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2025 Filed Jun 10, 2025 01:54 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 30,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-084073 · ownership.xml · nonDerivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,040 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2 · balance_after: Includes (i) 48,088 shares of Common Stock, and (ii) 30,952 RSUs which are subject to vesting as reported herein. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 23:33 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 17,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-071522 · ownership.xml · nonDerivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,088 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. F2 · balance_after: Includes (i) 24,747 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 5,975 RSUs granted to the Reporting Person on March 15, 2022, which are subject to vesting as previously reported. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:41 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 15,094 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 3 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679 F4 · shares: Reflects a grant of RSUs made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of Common Stock. The number of RSUs granted is equal to approximately $120,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest on the earlier of June 8, 2024 and the date of the Issuer's 2024 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date. Read SEC document |
| March 15, 2023 Filed Jun 12, 2023 21:41 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | Tax withholdingCommon Stock | 2,295 | $9.08 | $20,845.49 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 2 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,679 F2 · shares: Reflects shares of Common Stock sold to cover the Reporting Person's tax liability in connection with the vesting of the RSUs underlying the 2022 RSU Grant. F3 · price: Reflects the weighted average price at which the shares of Common Stock were sold. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2023 Filed Jun 12, 2023 21:41 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantCommon Stock | 17,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-015382 · doc4.xml · nonDerivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,974 F1 · shares: Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on March 15, 2022 under the Issuer's Non-Employee Director Compensation Program (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on March 18, 2022. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, one-third vested on March 15, 2023, and an additional one-third vests on each of March 15, 2024 and March 15, 2025, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date. Read SEC document |
| March 15, 2022 Filed Mar 18, 2022 21:47 UTC | Sight Sciences, Inc. SGHT · Entity 5537 | GrantRestricted Stock Units · Derivative | 17,923 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011607 · doc4.xml · derivative · entry 1 Larsen-Becker Brenda Jane · CIK 0001913647 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,923 Underlying: Common Stock · 17,923 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date. F2 · derivative.expiration_date: The RSUs vest in three substantially equal annual installments beginning on March 15, 2023, subject to the Reporting Person's continued service to the Issuer through each such vesting date. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.